Literature DB >> 17306347

Correlates of sexual function following vulvar excision.

Wendy M Likes1, Cheryl Stegbauer, Todd Tillmanns, James Pruett.   

Abstract

OBJECTIVES: The objectives were to evaluate associations between size of excision, grade of VIN, demographic variables, location of excision and laterality and sexual function and quality of life (QOL) in women with vulvar intraepithelial neoplasia (VIN) following vulvar excision.
METHODS: Forty-three women with VIN who had undergone a vulvar excision completed the Female Sexual Function Index (FSFI) and the European Organization for Research and Treatment of Cancer QLQ-C30 (QLQ C-30) scale to provide an assessment of sexual function and QOL. Medical records of the participants were reviewed for pathology results, operative reports, and medication history. Correlation and multiple regression analyses were performed to determine associations between collected variables and sexual function and QOL scores.
RESULTS: Most participants (n=43) were Caucasian (76.6%) and smoked (69.8%). Age significantly correlated with FSFI total score (Pearson r=-.470, p=.001), along with size of excision (r=-.412, p=.009). Neither VIN grade, location of excision, nor time since excision correlated with sexual function or QOL.
CONCLUSIONS: Older age and a more extensive vulvar excision were associated with poorer sexual function and QOL in women following surgical treatment for VIN. Further study with a larger sample and additional variables is needed to better understand the effect of vulvar excision on women's sexual function and QOL.

Entities:  

Mesh:

Year:  2007        PMID: 17306347     DOI: 10.1016/j.ygyno.2007.01.027

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

1.  Sexual health problems in French cancer survivors 2 years after diagnosis-the national VICAN survey.

Authors:  Ali Ben Charif; Anne-Déborah Bouhnik; Blandine Courbière; Dominique Rey; Marie Préau; Marc-Karim Bendiane; Patrick Peretti-Watel; Julien Mancini
Journal:  J Cancer Surviv       Date:  2015-12-21       Impact factor: 4.442

Review 2.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

3.  Sexual activity and function after surgical treatment in patients with (pre)invasive vulvar lesions.

Authors:  Donata Grimm; Christine Eulenburg; Oliver Brummer; Anna-Katharina Schliedermann; Fabian Trillsch; Katharina Prieske; Friederike Gieseking; Enzia Selka; Sven Mahner; Linn Woelber
Journal:  Support Care Cancer       Date:  2015-06-23       Impact factor: 3.603

4.  The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions.

Authors:  Mario Preti; Elmar Joura; Pedro Vieira-Baptista; Marc Van Beurden; Federica Bevilacqua; Maaike C G Bleeker; Jacob Bornstein; Xavier Carcopino; Cyrus Chargari; Margaret E Cruickshank; Bilal Emre Erzeneoglu; Niccolò Gallio; Debra Heller; Vesna Kesic; Olaf Reich; Colleen K Stockdale; Bilal Esat Temiz; Linn Woelber; François Planchamp; Jana Zodzika; Denis Querleu; Murat Gultekin
Journal:  J Low Genit Tract Dis       Date:  2022-06-21       Impact factor: 3.842

5.  Sexual function of patients with endometrial cancer enrolled in the Gynecologic Oncology Group LAP2 Study.

Authors:  Jeanne Carter; Helen Huang; Dana M Chase; Joan L Walker; David Cella; Lari Wenzel
Journal:  Int J Gynecol Cancer       Date:  2012-11       Impact factor: 3.437

6.  Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.

Authors:  S Daayana; E Elkord; U Winters; M Pawlita; R Roden; P L Stern; H C Kitchener
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

Review 7.  Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide.

Authors:  Laura B Huffman; Ellen M Hartenbach; Jeanne Carter; Joanne K Rash; David M Kushner
Journal:  Gynecol Oncol       Date:  2015-11-07       Impact factor: 5.482

Review 8.  Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology.

Authors:  Diana D Jeffery; Janice P Tzeng; Francis J Keefe; Laura S Porter; Elizabeth A Hahn; Kathryn E Flynn; Bryce B Reeve; Kevin P Weinfurt
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

9.  Quality of life valuations of HPV-associated cancer health states by the general population.

Authors:  E Lynne Conway; K Chip Farmer; William J Lynch; Guy L Rees; Gerard Wain; Jane Adams
Journal:  Sex Transm Infect       Date:  2012-05-29       Impact factor: 3.519

10.  Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK.

Authors:  Géraldine Dominiak-Felden; Catherine Cohet; Samantha Atrux-Tallau; Hélène Gilet; Amanda Tristram; Alison Fiander
Journal:  BMC Public Health       Date:  2013-11-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.